Company Description
Green Cures & Botanical Distribution (OTC Link: GRCU) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $722.7K.
GRCU stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of GRCU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Green Cures & Botanical Distribution (GRCU) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $722.7K, GRCU is classified as a micro-cap stock with approximately 7.2B shares outstanding.
Latest News
Green Cures & Botanical Distribution has 9 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, management, fda approval. View all GRCU news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Green Cures & Botanical Distribution (GRCU) currently stands at 30.4 thousand shares, down 7.3% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Green Cures & Botanical Distribution (GRCU) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
GRCU Company Profile & Sector Positioning
Green Cures & Botanical Distribution (GRCU) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GRCU often look at related companies in the same sector, including Nutra Pharma Corp (NPHC), Lords & Company Worldwide (LRDSF), Pure Harvest Cor (PHCG), Maple Leaf Green (MGWFF), and Neutrisci International (NRXCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GRCU's relative position within its industry.